—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
The Journal of Gene Medicine《基因医学杂志》
月刊 - 英国
  • The Journal of Gene Medicine《基因医学杂志》
  • SCIE外文期刊
  • 期发文量3
  • 国人占比90.00%
  • 知网外文库
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:4区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:3
    环比增速:100.00%
  • 期刊信息

  • 研究方向:医学-BIOTECHNOLOGY APPLIED MICROBIOLOGY生物工程与应用微生物;GENETICS HEREDITY遗传学;MEDICINE, RESEARCH EXPERIMENTAL医学:研究与实验
  • 国际刊号:ISSN 1099-498X;EISSN 1521-2254
  • 期刊语言:英语
    出版地区:英国
  • 投稿网址:https://wiley.atyponrex.com/journal/JGM
  • 电子邮箱:
  • 期刊官网:https://onlinelibrary.wiley.com/journal/15212254
  • 作者指南:
  • 出版商网址:http://www.wiley.com/WileyCDA/
  • 出版地址:JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ
  • 期刊简介:The Journal of Gene Medicine《基因医学杂志》(月刊). The aims and scope of The Journal of Gene Medicine include cutting-edge science of gene transfer and its applications in gene and cell therapy, genome editing with precision nucleases, epigenetic modifications of host genome by small molecules, siRNA, microRNA and other noncoding RNAs as therapeutic gene-modulating agents or targets, biomarkers for precision medicine, and gene-based prognostic/diagnostic studies.

  • 万维提示





  • 1、投稿方式:在线投稿。

    2、期刊网址:

    https://onlinelibrary.wiley.com/journal/15212254

    3、投稿网址:https://wiley.atyponrex.com/journal/JGM

    4、官网邮箱:JGMedoffice@wiley.com

    5、期刊刊期:月刊,一年出版12期。

    2021年1029日星期五

                              

     

    投稿须知【官网信息】

     

    The Journal of Gene Medicine

    Author Guidelines

    For additional tools visit Author Resources - an enhanced suite of online tools for Wiley journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.

    1. SUBMISSION

    Authors should kindly note that submission implies (i) that the content has not been published previously, in any language, in whole or in part, except as a brief abstract in the proceedings of a scientific meeting or symposium; (ii) that the manuscript is not currently under consideration for publication elsewhere; (iii) that all authors have read and approved the content of the manuscript; (iv) that all authors have declared all competing interests; and (v) that the work complies with Ethical Policies of the journal, and has been conducted under internationally accepted ethical standards after relevant ethical review.

    By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html

    Once you have prepared your submission in accordance with the Guidelines, new submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/JGM. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. For technical help with the submission system, please review our FAQs or contact submissionhelp@wiley.com.

    For all submission enquiries please contact the editorial office - Email: JGMedoffice@wiley.com.

    PEER REVIEW PROCESS

    Rapid peer review: Journal of Gene Medicine is committed to rapid publication of articles. It is the intention of the Editorial Office to peer review manuscripts and notify authors of the decision within four weeks. The full text of the accepted version is then published online via 'Accepted Articles' within 7 days of acceptance, prior to going through the production process. After production the final PDF version of the article will be published and the accepted version removed.

    Revised manuscripts should be submitted within three months of receiving the Editors’ decision, using the ‘create a revision’ option for the initial manuscript. Revised submissions should be accompanied by a letter specifying point-by-point how the author has responded to the reviewers’ and Editors’ comments.

    2. AIMS AND SCOPE

    Journal of Gene Medicine publishes cutting-edge science of gene transfer and its applications in gene and cell therapy, genome editing with precision nucleases, epigenetic modifications of host genome by small molecules, siRNA, microRNA and other noncoding RNAs as therapeutic gene-modulating agents or targets, biomarkers for precision medicine, and gene-based prognostic/diagnostic studies.

    Key areas of interest are the design of novel synthetic and viral vectors, novel therapeutic nucleic acids such as mRNA, modified microRNAs and siRNAs, antagomirs, aptamers, antisense and exon-skipping agents, refined genome editing tools using nucleic acid /protein combinations, physically or biologically targeted delivery and gene modulation, ex vivo or in vivo pharmacological studies including animal models, and human clinical trials.

    Papers presenting research into the mechanisms underlying transfer and action of gene medicines, the application of the new technologies for stem cell modification or nucleic acid based vaccines, the identification of new genetic or epigenetic variations as biomarkers to direct precision medicine, and the preclinical/clinical development of gene/expression signatures indicative of diagnosis or predictive of prognosis are also encouraged.

    3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

    The journal publishes Editorial, Commentary, Research Article, Review Article, Letter to the Editor and Correspondence.

    Review article is typically by invitation only, however proposals are welcome and may be accepted after editorial approval. Please contact the Editorial Office with your proposal before submitting a review article.

    Letter to the Editor and Correspondence should be kept brief, and be written in clear and balanced language, to allow healthy scientific discourse to take place.

    4. PREPARING THE SUBMISSION

    Abbreviations are not encouraged except for units of measurement and universally recognized abbreviations (e.g. DNA). When an abbreviation appears in the text for the first time, it should be placed in parentheses after the words for which it stands.

    Format. The main text file should be prepared using Microsoft Word using 1.5 line spacing.

    Parts of the Manuscript

    The text file should be presented in the following order: title page, abstract, keywords, main text, acknowledgments, conflict of interest statement, references, tables and figure legends. Figures and supporting information should be submitted in separate files.

    Title page

    The title page should contain:

    (i) A short informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);

    (ii) A short running title of no more than 40 characters, including spaces;

    (iii) The full name of the authors (refer to the journal's Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility); and

    (iv) The author's institutional affiliations where the work was conducted.

    The present address of any author, if different from where the work was carried out, should be supplied in a footnote.

    ……

    更多详情:

    https://onlinelibrary.wiley.com/page/journal/15212254/homepage/forauthors.html






欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码